VentriPoint Diagnostics Ltd VPT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CAD 0.23
- Day Range
- CAD 0.22–0.23
- 52-Week Range
- CAD 0.12–0.36
- Bid/Ask
- CAD 0.22 / CAD 0.23
- Market Cap
- CAD 34.50 Mil
- Volume/Avg
- 52,938 / 79,527
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 982.53
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.ventripoint.com
Valuation
|
Metric
|
VPT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 26.85 |
Price/Sales | 982.53 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
VPT
|
|---|---|
Quick Ratio | 2.00 |
Current Ratio | 2.06 |
Interest Coverage | — |
Quick Ratio
VPT
Profitability
|
Metric
|
VPT
|
|---|---|
Return on Assets (Normalized) | −85.67% |
Return on Equity (Normalized) | −121.73% |
Return on Invested Capital (Normalized) | −109.74% |
Return on Assets
VPT
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Qgnkdpxxh | Pjvljy | $185.4 Bil | |
SYK
| Stryker Corp | Qnjxwlgwg | Jtvkc | $127.7 Bil | |
BSX
| Boston Scientific Corp | Gysxjvvsz | Qhjtsth | $107.6 Bil | |
MDT
| Medtronic PLC | Gnknzztlx | Hfyvcb | $105.9 Bil | |
DXCM
| DexCom Inc | Vjgmymgz | Npx | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Sxfvtvtgc | Sqlpw | $52.0 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Qlgtnxvpf | Lcxf | $24.6 Bil | |
ALGN
| Align Technology Inc | Rvwqygpf | Zyjwns | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Rgmfglck | Lxrlxz | $18.7 Bil | |
PODD
| Insulet Corp | Rzpzmskvt | Jfsylgn | $11.6 Bil |